Segall Bryant & Hamill’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,057
Closed -$495K – 732
2022
Q2
$495K Hold
1,057
– – 0.01% 576
2022
Q1
$460K Hold
1,057
– – ﹤0.01% 613
2021
Q4
$490K Buy
1,057
+50
+5% +$22.1K ﹤0.01% 513
2021
Q3
$392K Hold
1,007
– – ﹤0.01% 657
2021
Q2
$446K Sell
1,007
-309
-23% -$135K ﹤0.01% 633
2021
Q1
$553K Buy
1,316
+291
+28% +$116K 0.01% 633
2020
Q4
$420K Buy
1,025
+26
+3% +$10.8K ﹤0.01% 604
2020
Q3
$413K Hold
999
– – 0.01% 577
2020
Q2
$387K Buy
999
+18
+2% +$6.74K 0.01% 639
2020
Q1
$308K Hold
981
– – 0.01% 672
2019
Q4
$360K Sell
981
-113
-10% -$35.8K 0.01% 711
2019
Q3
$280K Hold
1,094
– – ﹤0.01% 745
2019
Q2
$291K Sell
1,094
-28
-2% -$7.1K ﹤0.01% 742
2019
Q1
$298K Buy
1,122
+28
+3% +$8.07K ﹤0.01% 744
2018
Q4
$313K Buy
1,094
+6
+0.6% +$1.9K 0.01% 727
2018
Q3
$368K Hold
1,088
– – 0.01% 734
2018
Q2
$324K Buy
1,088
+100
+10% +$29.3K ﹤0.01% 742
2018
Q1
$266K Hold
988
– – 0.01% 541
2017
Q4
$245K Buy
988
+7
+0.7% +$1.73K 0.01% 527
2017
Q3
$239K Hold
981
– – 0.01% 525
2017
Q2
$236K Buy
+981
New +$222K 0.01% 525

Other funds holding HUM

Segall Bryant & Hamill's HUM Position: Q3 2022 in Review

Segall Bryant & Hamill sold out of Humana (HUM) in Q3 2022, closing a stake of 1,057 shares — an estimated $495K sold.

Segall Bryant & Hamill first reported a position in HUM in Q2 2017 and held it in 21 quarters. The position peaked at $553K in Q1 2021. 1,001 funds tracked by Wall St. Rank hold HUM as of Q3 2022.

  • Segall Bryant & Hamill reported no remaining Humana position as of Q3 2022 after selling out during the quarter.
  • Segall Bryant & Hamill sold 1,057 Humana shares in Q3 2022, an estimated $495K.
  • Segall Bryant & Hamill first reported a position in Humana in Q2 2017 and held it in 21 quarters.
  • Segall Bryant & Hamill's Humana position peaked at $553K in Q1 2021.
  • 1,001 funds tracked by Wall St. Rank held Humana as of Q3 2022.

Based on Segall Bryant & Hamill's 13F filing for Q3 2022, filed 14 Nov 2022.